| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10485077 | Value in Health | 2012 | 10 Pages |
Abstract
Indacaterol is expected to be comparable to formoterol, salmeterol, and tiotropium, providing higher FEV1 than formoterol and salmeterol and greater improvement in the SGRQ total score than tiotropium. Indacaterol 150 μg provided comparable improvement in dyspnea, while indacaterol 300 μg demonstrated the greatest response overall.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shannon MSc, Gorana PhD, Rupert MA, Cheryl MD, Roger PhD, Mario J.N.M. PhD, Gert PhD, Jeroen P. PhD,